Royalty Pharma: SCH Investment sells 100,000 shares
The EVP & Chairman, Partnering reported sales under a Rule 10b5-1 plan adopted March 20, 2026; family vehicles hold exchangeable interests.
Rhea-AI Filing Summary
At Royalty Pharma plc, EVP & Chairman, Partnering Christopher Hite reported that SCH Investment Partners LLC sold 100,000 Class A ordinary shares on September 22, 2026: 96,073 at a weighted average $58.5148 per share and 3,927 at $58.9261. The sales were made under a Rule 10b5-1 plan adopted March 20, 2026. Hite held 23,200 shares directly after the transactions; family vehicles also hold interests exchangeable into 866,410 Class A ordinary shares and Class E shares exchangeable into 1,238,789 Class A ordinary shares, with vesting conditions applying to the Class E shares.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 100,000 shares
Net Sell
3 txns
Insider
Hite Christopher
Role
EVP & Chairman, Partnering
Sold
100,000 shs ($5.85M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Ordinary Shares F1, F2 | 96,073 | $58.5148 | $5.62M |
| Sale | Class A Ordinary Shares F1, F3 | 3,927 | $58.9261 | $231K |
| holding | Class A Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Class A Ordinary Shares — 270,401 shares (Indirect, By SCH Investment Partners LLC);
Class A Ordinary Shares — 23,200 shares (Direct)
Footnotes (3)
- F1. All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 20, 2026.
- F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.88 to $58.87 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.88 to $59.00 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Class A ordinary shares sold: 100,000 shares
First sale: 96,073 shares
Second sale: 3,927 shares
+3 more
6 metrics
Class A ordinary shares sold
100,000 shares
SCH Investment Partners LLC sales on September 22, 2026
First sale
96,073 shares
Weighted average price of $58.5148 per share on September 22, 2026
Second sale
3,927 shares
Weighted average price of $58.9261 per share on September 22, 2026
Direct Class A ordinary shares held
23,200 shares
Held by Christopher Hite after the transactions on September 22, 2026
Class A ordinary shares exchangeable from RPI US Partners 2019, LP interests
866,410 shares
Interests held by family vehicles controlled by Christopher Hite
Class A ordinary shares exchangeable from Class E Ordinary Shares
1,238,789 shares
Class E Ordinary Shares of Royalty Pharma Holdings Ltd held by family vehicles; subject to vesting conditions
Key Terms
10b5-1 plan, weighted average price, limited partnership interests
3 terms
10b5-1 plan regulatory
"transactions were effected pursuant to a 10b5-1 plan"
A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.
weighted average price financial
"The reported price in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
limited partnership interests financial
"family vehicles controlled by the Reporting Person hold limited partnership interests"
An ownership stake in a limited partnership gives an investor the role of a limited partner who provides capital but does not run day-to-day operations; a separate general partner manages the business. It matters because limited partners share profits, losses, and tax benefits but generally cannot lose more than they invested and have little control or liquidity—think of it like quietly funding a small business while someone else manages it, with potential return and risk tied to the venture’s performance.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Were Christopher Hite’s RPRX sales made under a 10b5-1 plan?
Yes. The sales were made under a Rule 10b5-1 plan adopted by Christopher Hite on March 20, 2026.
What exchangeable holdings were disclosed for Christopher Hite’s RPRX family vehicles?
Family vehicles controlled by Christopher Hite hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 866,410 Class A ordinary shares. They also hold Class E Ordinary Shares of Royalty Pharma Holdings Ltd exchangeable into 1,238,789 Class A ordinary shares; the Class E shares are subject to vesting conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
